Turunc has advised Laboratoires Vivacy on a partnership with Burgeon Biotechnology. Allen Overy Shearman Sterling's Turkish affiliate law firm of Gedik Eraksoy reportedly advised Burgeon.
CMS and Schoenherr Advise on Synlab International's Sale of Eastern European Business Activities to Medicover Group
CMS has advised Synlab International on the sale of its business activities in Eastern Europe – including its entities in Croatia, North Macedonia, Romania, Slovenia, Turkiye, and Cyprus – to Medicover Group. Schoenherr advised Medicover.
Public-Private Partnerships in Healthcare: Global Models and Takeaways for Ukraine
Public-Private Partnerships (PPPs) have become an essential tool for governments worldwide to develop and modernise healthcare infrastructure. By leveraging private sector investment, expertise, and efficiency, PPPs help bridge funding gaps, improve healthcare accessibility, and ensure the long-term sustainability of medical facilities.
Schoenherr and Greenberg Traurig Advise on mBank's Financing for Unity Care and Salus' Cooperation with Enterprise Investors
Schoenherr has advised mBank on financing to Unity Care and Salus in cooperation with Enterprise Investors for the consolidation and modernization of outpatient healthcare facilities in Poland. Greenberg Traurig advised Enterprise Investors.
RTPR, Karanovic & Partners, White & Case, and Kinstellar Advise on Sale of Regina Maria Group to Mehilainen
RTPR and Karanovic & Partners have advised MidEuropa on the sale of Regina Maria Group to Mehilainen. White & Case advised Mehilainen. Kinstellar advised Blue Sea Capital on the sell-side as well. Reportedly, A&O Shearman's London office also advised MidEuropa while Bondoc & Asociatii also advised Mehilainen.
Competition in Focus: Serbia’s Private Healthcare Sector Under Regulatory Spotlight
The Serbian Competition Commission ("Commission") has published a Report on the sector inquiry of competition conditions in the private healthcare services market in the Republic of Serbia for the period from 2019 up to 2023 ("Inquiry").
Asters Advises EBRD on EUR 15 Million Financing for Yuria-Pharm
Asters has advised the European Bank for Reconstruction and Development on a EUR 15 million loan to Yuria-Pharm.